NASDAQ · XAIR
Beyond Air, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for XAIR: Nov 11, 2026
Beyond Air, Inc. Common Stock is expected to report earnings on 11/11/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-25.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · The Motley Fool- Fintel · Sep 1, 4:26 PM EDTLake Street Initiates Coverage of Beyond Air (XAIR) with Buy RecommendationFintel reports that on September 1, 2026, Lake Street initiated coverage of Beyond Air (NASDAQCM:XAIR) with a Buy recommendation. Analyst Price Forecast Suggests 670.78% Upside
- RTTNews · Aug 31, 8:42 AM EDTBeyond Air Receives FDA Breakthrough Device Designation For LungFit GO In NTM-PD(RTTNews) – Beyond Air, Inc. (XAIR) announced that the U.S. FDA has granted Breakthrough Device Designation to LungFit GO for the treatment of nontuberculous mycobacterial pulmonary disease.
- RTTNews · Aug 25, 7:47 AM EDTBeyond Air Enters Definitive Agreement With UNIVO For NeuroNOS Stake; Stock Down(RTTNews) – Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company, has entered into a definitive agreement to sell its majority stake in NeuroNOS Israel Ltd. to UNIVO Pharmaceutical Industries (UNVO), in exchange for equity and milestone payments.
- The Motley Fool · Aug 13, 11:58 PM EDTBeyond Air (XAIR) Q1 2027 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 3, 10:31 PM EDTTop Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentum(RTTNews) – Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and Autolus Therapeutics, following the releas
- The Motley Fool · Jun 26, 8:31 PM EDTBeyond Air (XAIR) Q4 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Feb 13, 2:23 PM ESTBeyond Air XAIR Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Jan 13, 11:05 AM ESTXLT Biopharma To Acquire 85% Of Beyond Air Subsidiary NeuroNOS In Autism Therapeutics Push; Stock Up(RTTNews) – XLT Biopharmaceuticals Ltd. (XTLB) has entered into a binding agreement to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air Inc. (XAIR), in deal that positions XTL as a new contender in the rapidly expanding autism therapeutics market.
- RTTNews · Dec 30, 7:49 AM ESTBeyond Air Names Dan Moorhead CFO(RTTNews) – Beyond Air, Inc. (XAIR), a commercial-stage medical device and biopharmaceutical company, on Tuesday announced that it has appointed Dan Moorhead as Chief Financial Officer, effective January 5, 2026.
- Fintel · Nov 11, 6:25 PM ESTD. Boral Capital Maintains Beyond Air (XAIR) Buy RecommendationFintel reports that on November 11, 2025, D. Boral Capital maintained coverage of Beyond Air (NasdaqCM:XAIR) with a Buy recommendation. Analyst Price Forecast Suggests 633.56% Upside
- The Motley Fool · Aug 18, 5:24 PM EDTBeyond Air Sales Jump 158 PercentRevenue climbed 157% year over year to $1.8 million (GAAP), but missed analyst estimates by 27.5% (GAAP).
- The Motley Fool · Aug 12, 5:52 PM EDTBeyond Air XAIR Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Beyond Air, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.